Dr. Neal Flomenberg MD Medical Oncologist

Dr. Neal Flomenberg is a medical oncologist in Philadelphia, Pennsylvania. He is affiliated with multiple hospitals in the area, including Lankenau Medical Center and Thomas Jefferson University Hospital. He received his medical degree from Jefferson Medical College and has been in practice for 38 years. Dr. Flomenberg accepts several types of health insurance, listed below. He is one of 15 doctors at Lankenau Medical Center and one of 19 at Thomas Jefferson University Hospital who specialize in Medical Oncology. He also speaks multiple languages, including Turkish, French and Spanish.

Are you Dr. Neal Flomenberg? Claim your profile to make edits or add details. Edit Profile

Office Location

See Contact Information

Specialty & Clinical Interests

Medical Oncologist: Hematologic

Clinical Interests: Transplants, Stem cell, - Blood & Marrow Transplantation- Two-step approach to myeloablative haploidentical stem cell transplantation - Hematologic Malignancies

Hospital Affiliation

Lankenau Medical Center
High performing in Cancer

Thomas Jefferson University Hospital
Ranked #17 in Cancer

Education & Medical Training

Albert Einstein College of Medicine at Jacobi Medical Center
Residency, Internal Medicine, 1976 - 1979

Memorial Sloan-Kettering Cancer Center
Fellowship, Hematology, 1980 - 1981

Jefferson Medical College
Class of 1976

Certifications & Licensure

American Board of Internal Medicine
Certified 33 years in Internal Medicine

American Board of Internal Medicine
Certified 30 years in Pulmonary Disease

American Board of Internal Medicine
Certified 23 years in Critical Care Medicine

WI State Medical License
Active through 2013

Awards, Honors & Recognition

Meaningful Use Stage 1 Certification, Centers for Medicare & Medicaid Services
2011

Elected Member, The American Society for Clinical Investigation
2005

Publications & Presentations

Recent advances in haploidentical stem cell transplantation.
Alpdogan, O.,Grosso, D.,Flomenberg, N.

Interleukin-15 administration increases graft-versus-tumor activity in recipients of haploidentical hematopoietic SCT.
Sauter, C. T.,Bailey, C. P.,Panis, M. M.,Biswas, C. S.,Budak-Alpdogan, T.,Durham, A.,Flomenberg, N.,Alpdogan, O.

Haploidentical hematopoietic SCT increases graft-versus-tumor effect against renal cell carcinoma.
Budak-Alpdogan, T.,Sauter, C. T.,Bailey, C. P.,Biswas, C. S.,Panis, M. M.,Civriz, S.,Flomenberg, N.,Alpdogan, O.

See all 5 publications

Insurances Accepted

  • Aetna Choice POS II
  • Aetna HMO
  • AmeriHealth Direct POS
  • AmeriHealth Direct POS Value Network
  • Amerihealth HMO
  • AmeriHealth HMO Value Network
  • AmeriHealth PPO
  • AmeriHealth PPO Value Network
  • Anthem Blue Access PPO
  • Anthem Blue Preferred HMO
  • BCBS Blue Card PPO
  • BCBS Illinois PPO
  • CIGNA HMO
  • CIGNA Open Access
  • CIGNA PPO
  • First Health PPO
  • GHI PPO
  • Great West PPO
  • HIP of New York - Select PPO
  • Horizon BCBS Direct Access
  • Horizon BCBS HMO
  • Horizon BCBS POS
  • Horizon BCBS PPO
  • Humana ChoiceCare Network PPO
  • MagnaCare PPO
  • Medical Mutual of Ohio SuperMed Plus
  • Medical Mutual of Ohio SuperMed POS
  • Multiplan PHCS PPO
  • Multiplan PPO
  • Oxford Health Freedom
  • Oxford Health Liberty
  • QualCare HMO
  • QualCare PPO
  • Sagamore Health Plus
  • United Healthcare - Direct Choice Plus POS
  • United Healthcare - Direct Options PPO
Find More Doctors
Doctor Finder

Our Doctor Finder includes most U.S. physicians. Doctors are not ranked, learn more.

Browse Doctors by

Specialty

Location

Search all Doctors

Profiles by Doximity

Your Message Has Been Submitted

As part of our research on the correction you submitted, you may be contacted at the email address provided.

Sorry, Your Message Could Not Be Submitted

Please try again later, or E-mail your message to doctors@usnews.com and include the Web address (URL) of the page that contains incorrect information.